Phase 2, study of Iovance autologous tumor infiltrating lymphocytes (Lifileucel, LN-144, LN-145, LN-145-S1) in patients with solid tumors Meeting Abstract

  


Authors: Gettinger, S.; Kluger, H.; Schoenfeld, A.; Betof Warner, A.; He, K.; Sukari, A.; Thomas, S.; Doger, B.; Lee, S.; Haefliger, S.; Goldberg, Z.; Cacovean, A.; Fiaz, R.; Chen, G.; Jagasia, M.; Graf Finckenstein, F.; Fardis, M.; Jimeno, A.
Abstract Title: Phase 2, study of Iovance autologous tumor infiltrating lymphocytes (Lifileucel, LN-144, LN-145, LN-145-S1) in patients with solid tumors
Meeting Title: 2021 World Conference on Lung Cancer
Keywords: lung cancer; adoptive cell therapy; tumor-infiltrating lymphocytes; non-small cell
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 10 Suppl.
Meeting Dates: 2021 Sep 8-14
Meeting Location: Virtual event
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-10-01
Start Page: S1012
End Page: S1013
Language: English
ACCESSION: WOS:000709606500335
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.08.335
Notes: Meeting Abstract: P14.05 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Allison Betof Warner
    76 Betof Warner
  2. Adam Jacob Schoenfeld
    131 Schoenfeld
Related MSK Work